Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study
Titel:
Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study
Auteur:
Benza, Raymond L. Simonneau, Gérald Ghofrani, Hossein-Ardeschir Corris, Paul A. Langleben, David Rosenkranz, Stephan White, R. James Cheng, Chin-Chang Campos, Frederico T.A. Figueiredo Kim, Hyung-Kwan Souza, Rogerio Chang, Mikyung Rahner, Claudia Meier, Christian Hoeper, Marius M.